# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 71-80 of 663 results.
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 11, 2020
First Received: Feb 24, 2017
Disease(s): Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult
Intervention(s): Decitabine, Bone marrow biopsy/aspirate, Peripheral blood draw, Skin biopsy, Buccal swab
Locations: University of Chicago, Chicago, Illinois, United States
University of Iowa, Iowa City, Iowa, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
... and 3 other locations.
Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia.
Status: Recruiting
Last Changed: Oct 25, 2018
First Received: Oct 17, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): NGS techniques
Locations: Hospital Reina Sofía, Córdoba, Spain
Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain
Hospital 12 de Octubre, Madrid, Spain
Clínica Universidad de Navarra, Pamplona, Spain
Hospital General Universitario, Salamanca, Spain
... and 3 other locations.
Genetic and Molecular Characteristics of Mexican Adults With Acute Myeloid Leukemia: a Prospective Multicentric Study.
Status: Not yet recruiting
Last Changed: Mar 17, 2020
First Received: Mar 17, 2020
Disease(s): Acute Myeloid Leukemia
Intervention(s): Molecular panel
Locations: Hospital Regional de Alta Especialidad Ixtapaluca, Ixtapaluca, Edo Mex, Mexico
Hospital Regional de Alta Especialidad Bajío, León, Guanajuato, Mexico
Hospital Universitario, Monterrey, Nuevo León, Mexico
Imss Umae 25, Monterrey, Nuevo León, Mexico
Hospital Regional de Alta Especialidad Ciudad Victoria, Ciudad Victoria, Tamaulipas, Mexico
... and 6 other locations.
A Study of Gilteritinib (ASP2215) Combined With Chemotherapy in Children, Adolescents and Young Adults With FMS-like Tyrosine Kinase 3 (FLT3)/Internal Tandem Duplication (ITD) Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Mar 26, 2020
First Received: Jan 27, 2020
Disease(s): Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
Intervention(s): gilteritinib, fludarabine, cytarabine, granulocyte colony-stimulating factor (G-CSF)
Locations: Site CA15001, Montreal, Quebec, Canada
A Phase Ib/II, Multicenter, Single Arm, Open-Label Study, To Evaluate the Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab Combination for Maintenance Treatment in Subjects With Acute Myeloid Leukemia Who Are 60 Years or Older - The BATTLE Study
Status: Recruiting
Last Changed: Jul 10, 2018
First Received: May 16, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): BL-8040, Atezolizumab
Locations: The University of Texas - Md Anderson Cancer Center - Leukemia Center, Houston, Texas, United States
Medical College of Wisconsin/Froedtert Hospital, Milwaukee, Wisconsin, United States
Fakultni Nemocnice Brno / University Hospital Brno Interni Hematologicka A Onkologicka Klinika / Internal Hematology and Oncology Clinic, Brno, Czechia
Fakultni Nemocnice Ostrava (Fno) / University Hospital Ostrava Klinika Hematoonkologie / Hematooncology Clinic, Ostrava, Czechia
Fakultni Nemocnice Kralovske Vinohrady Fnkv / University Hospital Kralovske Vinohrady Interní Hematologická Klinika Fnkv / Internal Hematology Clinic, Praha, Czechia
... and 8 other locations.
Flotetuzumab for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 19, 2020
First Received: Nov 12, 2019
Disease(s): Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Intervention(s): Cytarabine, Flotetuzumab
Locations: Children's National Medical Center, Washington, District of Columbia, United States
Riley Hospital for Children, Indianapolis, Indiana, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
... and 4 other locations.
Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Mar 13, 2020
First Received: Dec 20, 2019
Disease(s): Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Intervention(s): Gemtuzumab Ozogamicin, Quality-of-Life Assessment, Questionnaire Administration, Talazoparib, Talazoparib Tosylate
Locations: Roswell Park Cancer Institute, Buffalo, New York, United States
Multi-CAR T Cell Therapy for Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Oct 17, 2018
First Received: Jul 19, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): Muc1/CLL1/CD33/CD38/CD56/CD123-specific gene-engineered T cells
Locations: Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, KunMing, Yunnan, China
A Safety and Efficacy Study of Oral Venetoclax Tablets and Injectable Azacitidine Versus Best Supportive Care as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy to Evaluate Improvement in Relapse-Free Survival
Status: Recruiting
Last Changed: Mar 26, 2020
First Received: Sep 25, 2019
Disease(s): Acute Myeloid Leukemia (AML)
Intervention(s): Venetoclax, Azacitidine, Best Supportive Care (BSC)
Locations: University of Alabama at Birmingham - Main /ID# 214523, Birmingham, Alabama, United States
Mitchell Cancer Institute /ID# 216443, Mobile, Alabama, United States
University of Arkansas for Medical Sciences /ID# 218105, Little Rock, Arkansas, United States
Compassionate Cancer Care Research Group - Fountain Valley /ID# 216156, Fountain Valley, California, United States
UCSD Moores Cancer Center - LaJolla /ID# 216065, La Jolla, California, United States
... and 157 other locations.
CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status: Recruiting
Last Changed: Apr 01, 2019
First Received: Apr 01, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): CART-19
Locations: The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China